Terrance Johns


  • The University of Western Australia (M560), 35 Stirling Highway,

    6009 Perth


  • 1109 Citations
  • 18 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Terrance Johns is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Glioblastoma Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Glioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Ectopic Pregnancy Medicine & Life Sciences
Cells Chemical Compounds
Mitochondrial DNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2018

  • 1109 Citations
  • 18 h-Index
  • 38 Article
  • 1 Editorial
  • 1 Review article
5 Citations (Scopus)

Activation of ERBB4 in glioblastoma can contribute to increased tumorigenicity and influence therapeutic response

Donoghue, J. F., Kerr, L. T., Alexander, N. W., Greenall, S. A., Longano, A. B., Gottardo, N. G., Wang, R., Tabar, V., Adams, T. E., Mischel, P. S. & Johns, T. G., 1 Aug 2018, In : Cancers. 10, 8, 243.

Research output: Contribution to journalArticle

Open Access
Messenger RNA
1 Citation (Scopus)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors

Endersby, R., Whitehouse, J., Hii, H., Greenall, S. A., Johns, T. G. & Gottardo, N. G., May 2018, In : Neoplasia. 20, 5, p. 432-442 11 p.

Research output: Contribution to journalArticle

Open Access
Brain Neoplasms
Epidermal Growth Factor Receptor

Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors

Hoque, M., Abbassi, R. H., Froio, D., Man, J., Johns, T. G., Stringer, B. W., Day, B. W., Pajic, M., Kassiou, M. & Munoz, L., 1 Aug 2018, In : Pharmacological Research. 134, p. 166-178 13 p.

Research output: Contribution to journalArticle

Protein Kinase Inhibitors
Drug Delivery Systems
1 Citation (Scopus)

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3

Greenall, S. A., Donoghue, J., Johns, T. G. & Adams, T. E., 1 Aug 2018, In : Translational Oncology. 11, 4, p. 971-978 8 p.

Research output: Contribution to journalArticle

Open Access
Insulin-Like Growth Factor II
Neutralizing Antibodies
Hepatocellular Carcinoma
Cell Line
3 Citations (Scopus)

PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein

Daniel, P. M., Filiz, G., Brown, D. V., Christie, M., Waring, P. M., Zhang, Y., Haynes, J. M., Pouton, C., Flanagan, D., Vincan, E., Johns, T. G., Montgomery, K., Phillips, W. A. & Mantamadiotis, T., 1 Jan 2018, In : Neuro-Oncology. 20, 10, p. 1344-1355 12 p.

Research output: Contribution to journalArticle

Cyclic AMP Response Element-Binding Protein
1-Phosphatidylinositol 4-Kinase
Neural Stem Cells

Projects 2018 2021